Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.44B | $4.27B | $7.44B | $11.1B | $11.6B | $12.7B | $14.1B | $14.8B | $15.4B | $16.6B |
| Revenue growth | — | -33.7% | 74.3% | 49.4% | 4.5% | 9.2% | 10.8% | 5.4% | 3.6% | 8.2% |
| Gross profit | $3.86B | $2.04B | $3.88B | $6.34B | $6.49B | $6.98B | $7.32B | $8.08B | $8.53B | $9.00B |
| Gross margin | 59.9% | 47.9% | 52.2% | 57.0% | 55.8% | 55.0% | 52.1% | 54.5% | 55.6% | 54.2% |
| Operating income | $1.43B | $897M | $1.24B | $2.38B | $2.48B | $2.89B | $2.60B | $3.19B | $2.59B | $3.58B |
| Operating margin | 22.3% | 21.0% | 16.6% | 21.4% | 21.3% | 22.8% | 18.5% | 21.5% | 16.9% | 21.5% |
| Net income | $847M | $378M | $586M | $1.25B | $1.32B | $2.15B | $1.44B | $2.18B | $1.44B | $2.08B |
| Net margin | 13.2% | 8.9% | 7.9% | 11.3% | 11.4% | 16.9% | 10.2% | 14.7% | 9.4% | 12.5% |
| EPS (diluted) | $4.54 | $0.47 | $0.53 | $0.88 | $0.93 | $1.50 | $1.01 | $1.55 | $1.05 | $1.53 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $961M | $1.75B | $1.61B | $2.47B | $2.46B | $2.87B | $2.84B | $1.33B | $2.22B | $1.99B |
| Capital expenditures | $180M | $66.0M | $180M | $330M | $461M | $423M | $353M | $425M | $563M | $486M |
| Free cash flow | $781M | $1.68B | $1.43B | $2.14B | $2.00B | $2.45B | $2.48B | $904M | $1.66B | $1.50B |
| Share buybacks | $519M | $399M | — | — | $0.00 | $0.00 | $379M | $706M | $1.11B | $9.00M |
| Dividends paid | $386M | $55.0M | $232M | $844M | $846M | $955M | $1.08B | $1.14B | $1.19B | $1.25B |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $1.79B | $90.0M | $83.0M | $75.0M | $240M | $567M | $535M | $267M | $510M | $1.03B |
| Total assets | $9.79B | $15.7B | $48.9B | $49.5B | $49.8B | $50.6B | $51.8B | $52.1B | $53.4B | $55.5B |
| Total liabilities | $7.66B | $8.08B | $26.4B | $26.3B | $25.9B | $25.6B | $26.7B | $26.5B | $29.2B | $29.9B |
| Long-term debt | $4.33B | $4.88B | $14.2B | $12.8B | $11.1B | $11.6B | $11.1B | $9.95B | $12.9B | $13.0B |
| Shareholders' equity | $6.51B | $7.40B | $22.5B | $23.3B | $23.8B | $25.0B | $25.1B | $25.7B | $24.2B | $25.5B |
| Retained earnings | $2.27B | $914M | $1.18B | $1.58B | $2.06B | $3.20B | $3.54B | $4.56B | $4.79B | $5.62B |
| Shares (wtd avg diluted) | 187M | 791M | 1.10B | 1.42B | 1.42B | 1.43B | 1.43B | 1.41B | 1.37B | 1.36B |
Every figure is extracted from Keurig Dr Pepper Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.